RAB7A and familial pancreatic carcinoma: The results showed that there was a significant difference in overall survival (P = 0.004), progression-free interval (P = 0.004), and disease-specific survival (P = 0.001) between the pancreatic cancer patients in the high and low RAB7A expression groups.